M. Guaraldi

960 total citations
27 papers, 566 citations indexed

About

M. Guaraldi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, M. Guaraldi has authored 27 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in M. Guaraldi's work include Lung Cancer Treatments and Mutations (12 papers), Lung Cancer Research Studies (10 papers) and Cancer Treatment and Pharmacology (8 papers). M. Guaraldi is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Lung Cancer Research Studies (10 papers) and Cancer Treatment and Pharmacology (8 papers). M. Guaraldi collaborates with scholars based in Italy. M. Guaraldi's co-authors include Andrea Martoni, F Pannuti, Barbara Melotti, E Piana, Maria Grazia Ghi, H. Koussis, Andrea Bonetti, Adriano Paccagnella, A. Farris and Alessandro Gava and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

M. Guaraldi

26 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Guaraldi Italy	14	332	261	203	182	91	27	566
Jere T. W. Licciardello United States	7	194 0.6×	160 0.6×	128 0.6×	127 0.7×	66 0.7×	8	463
Richard H. Bromer United States	9	299 0.9×	168 0.6×	340 1.7×	231 1.3×	96 1.1×	14	552
A. Millà Spain	10	183 0.6×	132 0.5×	127 0.6×	151 0.8×	56 0.6×	15	367
Kelly K. Curtis United States	12	130 0.4×	146 0.6×	61 0.3×	110 0.6×	107 1.2×	25	375
Ping‐Tsung Chen Taiwan	14	201 0.6×	126 0.5×	54 0.3×	120 0.7×	69 0.8×	35	436
Akiko Todaka Japan	16	390 1.2×	372 1.4×	43 0.2×	335 1.8×	66 0.7×	80	688
Daniel U. Riihimaki United States	12	331 1.0×	137 0.5×	104 0.5×	289 1.6×	29 0.3×	14	611
Ayşe Nur Demiral Türkiye	13	141 0.4×	197 0.8×	101 0.5×	66 0.4×	68 0.7×	31	402
Ka On Lam Hong Kong	13	210 0.6×	171 0.7×	51 0.3×	122 0.7×	48 0.5×	40	501
Miriam E. Vincent United States	9	164 0.5×	499 1.9×	186 0.9×	786 4.3×	74 0.8×	16	980

Countries citing papers authored by M. Guaraldi

Since Specialization

Citations

This map shows the geographic impact of M. Guaraldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Guaraldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Guaraldi more than expected).

Fields of papers citing papers by M. Guaraldi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Guaraldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Guaraldi. The network helps show where M. Guaraldi may publish in the future.

Co-authorship network of co-authors of M. Guaraldi

This figure shows the co-authorship network connecting the top 25 collaborators of M. Guaraldi. A scholar is included among the top collaborators of M. Guaraldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Guaraldi. M. Guaraldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ghi, Maria Grazia, Adriano Paccagnella, Daris Ferrari, et al.. (2014). Concomitant chemoradiation (CRT) or cetuximab/RT (CET/RT) versus induction Docetaxel/ Cisplatin/5-Fluorouracil (TPF) followed by CRT or CET/RT in patients with Locally Advanced Squamous Cell Carcinoma of Head and Neck (LASCCHN). A randomized phase III factorial study (NCT01086826).. Journal of Clinical Oncology. 32(15_suppl). 6004–6004. 48 indexed citations

Ghi, Maria Grazia, Adriano Paccagnella, Daris Ferrari, et al.. (2012). Cetuximab/radiotherapy (CET+RT) versus concomitant chemoradiotherapy (cCHT+RT) with or without induction docetaxel/cisplatin/5-fluorouracil (TPF) in locally advanced head and neck squamous cell carcinoma (LASCCHN): Preliminary results on toxicity of a randomized, 2x2 factorial, phase II-III study (NCT01086826).. Journal of Clinical Oncology. 30(15_suppl). 5513–5513. 11 indexed citations

Paccagnella, Adriano, Maria Grazia Ghi, L. Loreggian, et al.. (2009). Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study. Annals of Oncology. 21(7). 1515–1522. 127 indexed citations

Martoni, Andrea, Antonella Marino, Francesca Sperandi, et al.. (2004). Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer. European Journal of Cancer. 41(1). 81–92. 61 indexed citations

Guaraldi, M., et al.. (2001). Phase II Study of Sequential Treatment of Advanced Non–Small-Cell Lung Cancer: Three Cycles of High-Dose Epirubicin Plus Cisplatin Followed by Weekly Vinorelbine. Clinical Lung Cancer. 3(1). 43–46. 2 indexed citations

Martoni, Andrea, Francesca Di Fabio, M. Guaraldi, et al.. (2001). Prospective Phase II Study of Single-Agent Gemcitabine in Untreated Elderly Patients With Stage IIIB/IV Non–Small-Cell Lung Cancer. American Journal of Clinical Oncology. 24(6). 614–617. 33 indexed citations

Pinto, Carmine, Antonella Marino, M. Guaraldi, et al.. (2001). Combination Chemotherapy With Mitoxantrone, Methotrexate, and Mitomycin (MMM Regimen) in Malignant Pleural Mesothelioma. American Journal of Clinical Oncology. 24(2). 143–147. 23 indexed citations

Martoni, Andrea, M. Guaraldi, & E Piana. (1999). Anthracyclines in non-small-cell lung cancer: Do they have a therapeutic role?. Annals of Oncology. 10. S19–S23. 5 indexed citations

Martoni, Andrea, M. Guaraldi, E Piana, et al.. (1998). Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer. Lung Cancer. 22(1). 31–38. 25 indexed citations

10.

Martoni, Andrea, Bruna Angelelli, M. Guaraldi, Elena Strocchi, & F Pannuti. (1996). An open randomised cross-over study on granisetron versus ondansetron in the prevention of acute emesis induced by moderate dose cisplatin-containing regimens. European Journal of Cancer. 32(1). 82–85. 17 indexed citations

11.

Martoni, A., et al.. (1994). Combined Chemo-Immuno-Hormonotherapy of Advanced Renal Cell Carcinoma. Journal of Chemotherapy. 6(5). 349–353. 4 indexed citations

12.

Martoni, Andrea, et al.. (1992). A phase II study of high-dose epirubicin plus cisplatinum in advanced non-small-cell lung cancer (NSCLC). Annals of Oncology. 3(10). 864–866. 14 indexed citations

13.

Martoni, Andrea, et al.. (1992). Weekly regimen of 5-FU vs 5-FU + intermediate dose folinic acid in the treatment of advanced colorectal cancer.. PubMed. 12(3). 607–12. 10 indexed citations

14.

Camaggi, Carlo Maurizio, Elena Strocchi, Andrea Martoni, et al.. (1992). Idarubicin metabolism and pharmacokinetics after intravenous and oral administration in cancer patients: a crossover study. Cancer Chemotherapy and Pharmacology. 30(4). 307–316. 30 indexed citations

15.

Martoni, Andrea, Barbara Melotti, M. Guaraldi, & F Pannuti. (1991). Activity of high-dose epirubicin in advanced non-small cell lung cancer. European Journal of Cancer and Clinical Oncology. 27(10). 1231–1234. 26 indexed citations

16.

Martoni, Andrea, et al.. (1991). Controlled Clinical Study on the Use of Dichloromethylene Diphosphonate in Patients with Breast Carcinoma Metastasizing to the Skeleton. Oncology. 48(2). 97–101. 41 indexed citations

17.

Guaraldi, M., Andrea Martoni, Umberto Caliceti, et al.. (1991). 5-Fluorouracil + folinic acid with cisplatinum and bleomyein in the treatment of advanced head and neck squamous cell carcinoma. Annals of Oncology. 2(5). 379–381. 5 indexed citations

18.

Martoni, A., Barbara Melotti, M. Guaraldi, et al.. (1990). High-dose epiribicin for untreated patients with advanced tumours: a phase I study. European Journal of Cancer and Clinical Oncology. 26(11-12). 1137–1140. 16 indexed citations

19.

Martoni, Andrea, et al.. (1990). Comparative Phase II Study of Idarubicin versus Doxorubicin in Advanced Breast Cancer. Oncology. 47(5). 427–432. 24 indexed citations

20.

Martoni, Andrea, et al.. (1989). A Randomized Clinical Trial with a Weekly Regimen of 5-Fluorouracil with or without Folinic Acid in Advanced Gastrointestinal Adenocarcinomas: A Preliminary Report. Journal of Chemotherapy. 1(3). 197–202. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact